Follow us on:

Linkedin Facebook

Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Hikma Pharmaceuticals plc

Hikma Pharmaceuticals CEO Riad Mishlawi steps down, Executive Chairman assumes role

Hikma Pharmaceuticals has announced that Riad Mishlawi has stepped down as Chief Executive Officer and as a board member by mutual agreement...
GSK plc

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026...
Ethtry plc

Ethtry adds two new Advisory Board members

Ethtry has added Mike Foy and Marc Degen to its new Advisory Board, bringing experience across digital assets, fintech and Web3 ventures...
GSK

GSK receives US FDA Orphan Drug Designation for SCLC treatment risvutatug rezetecan

GSK has announced that its B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, has been granted Orphan Drug Designation by the US FDA for small-cell lung cancer...

Oxford Nanopore names Francis Van Parys as new CEO from March 2026

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer, effective 2 March 2026...
Smith & Nephew plc

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow...
Ethtry plc

Ethtry appoints John Robinson as Company Secretary

Ethtry has appointed John Robinson as Company Secretary, bringing over 28 years of audit, assurance and M&A experience across international markets including Europe, Africa and emerging technology sectors...
Halma plc

Halma Plc acquires E2S Group for £230m to expand industrial safety capabilities

Halma has acquired E2S Group for £230m, adding a manufacturer of notification and detection devices used in hazardous industrial settings...
Ethtry plc

Ethtry Plc closes £5.3m fundraise, CEO subscribes

Ethtry PLC has received a further £86,000 in subscription monies, bringing the total raised to £5.302m and confirming the Fundraise is now closed...
Faron Pharmaceuticals

Faron Pharmaceuticals appoints new CFO Jurriaan Dekkers

Faron Pharmaceuticals has named Jurriaan Dekkers as its new Chief Financial Officer from 1 December 2025...
Aptamer Group

Aptamer Group AGM statement highlights contract wins and growing order book

Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
intravenous (IV) line

AstraZeneca wins US approval for Imfinzi in early gastric and GEJ cancers

AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
AstraZeneca

AstraZeneca Plc to invest $2 billion in major Maryland manufacturing expansion

AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg...
GSK

GSK subsidiary TESARO starts legal action over Jemperli licence dispute

TESARO, part of GSK, has filed a case in the Delaware Chancery Court claiming AnaptysBio has breached its licence agreement for the cancer treatment Jemperli...
Halma plc

Halma Plc posts interim results and raises dividend by 7%

Halma plc has released its interim results for the six months to 30 September 2025, with full details available on its website and through the FCA’s National Storage Mechanism...
CVS Group plc

CVS Group reports steady sales growth and progress on strategy

CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...
Ethtry plc

Ethtry appoints Patrick Chopard as new CEO

Ethtry PLC has named Patrick Chopard as its new Chief Executive Officer, bringing more than 15 years of financial markets experience from roles at Barclays, Deutsche Bank and Nomura...
Aptamer Group

Aptamer Group secures £192k contracts with global pharma, boosting FY26 order book to £1.95m

Aptamer Group announced two new contracts worth £192,000, including a fourth engagement with a top five global pharmaceutical company and a new deal targeting acute myeloid leukaemia...
Nuformix

Nuformix receives FDA clarification request and reports 408% oversubscription in Open Offer

Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses...
Cizzle Biotechnology Holdings

Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership

Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Interviews

Hikma Pharmaceuticals plc

Hikma Pharmaceuticals CEO Riad Mishlawi steps down, Executive Chairman assumes role

Hikma Pharmaceuticals has announced that Riad Mishlawi has stepped down as Chief Executive Officer and as a board member by mutual agreement...
GSK plc

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026...
Ethtry plc

Ethtry adds two new Advisory Board members

Ethtry has added Mike Foy and Marc Degen to its new Advisory Board, bringing experience across digital assets, fintech and Web3 ventures...
GSK

GSK receives US FDA Orphan Drug Designation for SCLC treatment risvutatug rezetecan

GSK has announced that its B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, has been granted Orphan Drug Designation by the US FDA for small-cell lung cancer...

Oxford Nanopore names Francis Van Parys as new CEO from March 2026

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer, effective 2 March 2026...
Smith & Nephew plc

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow...
Ethtry plc

Ethtry appoints John Robinson as Company Secretary

Ethtry has appointed John Robinson as Company Secretary, bringing over 28 years of audit, assurance and M&A experience across international markets including Europe, Africa and emerging technology sectors...
Halma plc

Halma Plc acquires E2S Group for £230m to expand industrial safety capabilities

Halma has acquired E2S Group for £230m, adding a manufacturer of notification and detection devices used in hazardous industrial settings...
Ethtry plc

Ethtry Plc closes £5.3m fundraise, CEO subscribes

Ethtry PLC has received a further £86,000 in subscription monies, bringing the total raised to £5.302m and confirming the Fundraise is now closed...
Faron Pharmaceuticals

Faron Pharmaceuticals appoints new CFO Jurriaan Dekkers

Faron Pharmaceuticals has named Jurriaan Dekkers as its new Chief Financial Officer from 1 December 2025...
Aptamer Group

Aptamer Group AGM statement highlights contract wins and growing order book

Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
intravenous (IV) line

AstraZeneca wins US approval for Imfinzi in early gastric and GEJ cancers

AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
AstraZeneca

AstraZeneca Plc to invest $2 billion in major Maryland manufacturing expansion

AstraZeneca has confirmed a $2 billion investment to expand its manufacturing presence in Maryland, including a larger biologics facility in Frederick and a new clinical manufacturing site in Gaithersburg...
GSK

GSK subsidiary TESARO starts legal action over Jemperli licence dispute

TESARO, part of GSK, has filed a case in the Delaware Chancery Court claiming AnaptysBio has breached its licence agreement for the cancer treatment Jemperli...
Halma plc

Halma Plc posts interim results and raises dividend by 7%

Halma plc has released its interim results for the six months to 30 September 2025, with full details available on its website and through the FCA’s National Storage Mechanism...
CVS Group plc

CVS Group reports steady sales growth and progress on strategy

CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...
Ethtry plc

Ethtry appoints Patrick Chopard as new CEO

Ethtry PLC has named Patrick Chopard as its new Chief Executive Officer, bringing more than 15 years of financial markets experience from roles at Barclays, Deutsche Bank and Nomura...
Aptamer Group

Aptamer Group secures £192k contracts with global pharma, boosting FY26 order book to £1.95m

Aptamer Group announced two new contracts worth £192,000, including a fourth engagement with a top five global pharmaceutical company and a new deal targeting acute myeloid leukaemia...
Nuformix

Nuformix receives FDA clarification request and reports 408% oversubscription in Open Offer

Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses...
Cizzle Biotechnology Holdings

Cizzle Biotechnology to validate CIZ1B lung cancer test through NHS-linked partnership

Cizzle Biotechnology Chairman Derek Bickerstaff has confirmed the company has signed a Letter of Intent with a confidential NHS-affiliated diagnostics partner...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Health

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple